Rigel Pharmaceuticals (RIGL) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103.28% |
| Dec 31, 2025 | -63.23% |
| Sep 30, 2025 | -163.46% |
| Jun 30, 2025 | 170.06% |
| Mar 31, 2025 | -316.88% |
| Dec 31, 2024 | -67.68% |
| Sep 30, 2024 | 49.24% |
| Jun 30, 2024 | 245.30% |
| Mar 31, 2024 | 42.89% |
| Dec 31, 2023 | -271.63% |
| Sep 30, 2023 | -139.85% |
| Jun 30, 2023 | -46.12% |
| Mar 31, 2023 | 392.69% |
| Dec 31, 2022 | -302.89% |
| Sep 30, 2022 | 5.67% |
| Jun 30, 2022 | -56.43% |
| Mar 31, 2022 | 150.28% |
| Dec 31, 2021 | 78.84% |
| Sep 30, 2021 | -184.01% |
| Jun 30, 2021 | 727.31% |
| Mar 31, 2021 | -66.71% |
| Dec 31, 2020 | -6,420.41% |
| Sep 30, 2020 | 101.12% |
| Jun 30, 2020 | -138.57% |
| Mar 31, 2020 | 237.00% |
| Dec 31, 2019 | -222.66% |
| Sep 30, 2019 | 83.14% |
| Jun 30, 2019 | -1,773.74% |
| Mar 31, 2019 | -110.96% |
| Dec 31, 2018 | 513.03% |
| Sep 30, 2018 | -114.40% |
| Jun 30, 2018 | 1,259.84% |
| Mar 31, 2018 | -85.21% |
| Dec 31, 2017 | 284.91% |
| Sep 30, 2017 | 11.13% |
| Jun 30, 2017 | -133.55% |
| Mar 31, 2017 | 370.64% |
| Dec 31, 2016 | -928.49% |
| Sep 30, 2016 | -90.60% |
| Jun 30, 2016 | 136.58% |
| Mar 31, 2016 | -698.22% |
| Dec 31, 2015 | -77.08% |
| Sep 30, 2015 | 183.71% |
| Jun 30, 2015 | -192.42% |
| Mar 31, 2015 | 1,051.74% |
| Dec 31, 2014 | 121.58% |
| Sep 30, 2014 | -223.36% |
| Jun 30, 2014 | 250.94% |
| Mar 31, 2014 | -223.24% |
| Dec 31, 2013 | 182.63% |
| Sep 30, 2013 | 55.49% |
| Jun 30, 2013 | -2,042.67% |
| Mar 31, 2013 | -89.90% |
| Dec 31, 2012 | 928.15% |
| Sep 30, 2012 | -84.22% |
| Jun 30, 2012 | 21.12% |
| Mar 31, 2012 | 7,038.78% |
| Dec 31, 2011 | 99.80% |
| Sep 30, 2011 | -240.73% |
| Jun 30, 2011 | 2.48% |
| Mar 31, 2011 | 227.68% |
| Dec 31, 2010 | -29.59% |